Vascular reactivity shows biphasic changes after severe trauma or shock. Our aim was to elucidate the mechanisms of biphasic-changed vascular reactivity after haemorrhagic shock by observing the regulation of angiopoietin-1 (Ang-1) and angiopoietin-2 (Ang-2) on it.
Introduction
Vascular hyporeactivity (i.e. greatly reduced vascular reactivity to vasoconstrictors and vasodilators), which exists in the late phase of severe trauma or shock, could influence the treatment, prognosis, and outcome of these severe disorders.
1,2 Membrane hyperpolarization, receptor desensitization, and calcium desensitization of vascular smooth muscle cells (VSMCs) have been shown to contribute to vascular hyporeactivity, and recovery of these functions does not fully restore vascular reactivity. 3 -5 Our previous study revealed that vascular reactivity shows biphasic changes after severe trauma or shock, which is increased at early shock and decreased at later stages. 6 Hence, studying the biphasic changes of vascular reactivity may help us to understand the development and treatment of vascular hyporeactivity. Angiopoietin-1 (Ang-1) and angiopoietin-2 (Ang-2) have critical roles in the remodelling, maturation, and stabilization of the vasculature through binding to, and competitively regulating, the endothelial cell-selective receptor tyrosine kinase Tie2. Ang-1 promotes the maturation of blood vessels and prevents damage to endothelial cells, whereas Ang-2 has the opposite effects. 7 Whether Ang-1 and Ang-2 participate in the regulation of biphasic-changed vascular reactivity after shock and their underlying mechanisms of action are not known.
Studies have shown that Ang-1 and Ang-2 appear to have different expression profiles after ischaemia or hypoxia in many tissues, 8, 9 and can regulate Tie2 and its downstream pathway [Akt-endothelial nitric oxide synthase (eNOS) and extracellular signal-regulated kinase (Erk)-inducible nitric oxide synthase (iNOS)] to regulate the production of nitric oxide (NO), an important regulatory molecule of vascular reactivity. 3, 4, 7 Hence, it is hypothesized that Ang-1 and Ang-2 may participate in the regulation of vascular reactivity after shock and that the main mechanism may be associated with the Tie2-Akt-eNOS and/or Tie2-Erk-iNOS signal pathway.
To confirm this hypothesis, haemorrhagic-shock rats and hypoxiatreated superior mesenteric arteries (SMAs) with intact endothelia and co-cultured VSMCs and vascular endothelial cells (VECs) were used to investigate: (i) the effect of regulation by Ang-1 and Ang-2 on vascular reactivity after haemorrhagic shock; (ii) whether Ang-1 and Ang-2 regulate vascular reactivity after haemorrhagic shock through the Tie2-NO pathway; and (iii) whether Ang-1 and Ang-2 regulate vascular reactivity after haemorrhagic shock via a different signal pathway: Tie2-Akt-eNOS and Tie2-Erk-iNOS.
Methods

Ethical approval of the study protocol
The investigation conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication number 85 -23, revised 1996). The study protocol was approved by the Research Council and Animal Care and Use Committee of the Research Institute of Surgery, Daping Hospital, Third Military Medical University (Chongqing, China).
Animal management and preparation of the shock model
Male and female Sprague-Dawley rats (220-240 g) were anaesthetized with sodium pentobarbital (initial dosage, 30 mg/kg, ip) and jingsongling ('xylidinothiazole'; initial dosage, 0.1 mg/kg, im). The two drugs were added until the rats had no response to a needle stimulus. 5 Anaesthetized rats were placed on a warming plate to maintain the body temperature at 378C. Aseptic techniques were adopted for all surgical procedures. Right femoral arteries were catheterized with polyethylene catheters (outer diameter, 0.965 mm; inner diameter, 0.58 mm) for monitoring the mean arterial blood pressure (MAP) and bleeding. Rats in the shock group underwent haemorrhage (within 10 min) from the right femoral arterial catheters to reduce the MAP to 40 mmHg, and this MAP was maintained for different times (10, 30 min, 1, 2, or 4 h) by the withdrawal or addition of shed blood. 6 Rats in the normal control group experienced the same management but without haemorrhage. At the end of shock, rats were killed with a lethal dose of sodium pentobarbital (100 mg/kg, iv). A laparotomy was then carried out to obtain SMAs with intact endothelia.
Preparation of hypoxia-treated SMAs and hypoxia-treated co-cultured VECs and VSMCs
SMAs and their first-class arborizations with intact endothelia were incubated with 5 mL of Krebs-Henseleit (K -H) solution. 10 Reagents (e.g. exogenous Ang-1 and Ang-2) were added according to the treatments of different groups. SMAs were then put into a hypoxia compartment and hypoxic gas (mixture of 95% N 2 and 5% CO 2 ) was bubbled through at 3 L/min for 15 min. This was followed by occlusion and resting for 10 min. The bubbling in of hypoxic gas and resting were repeated five times until the O 2 concentration was ,0.2%. 10 The airtight hypoxia compartment was then occluded and SMAs were cultured under this condition for different times (10 min, 1, 3, 4, or 5 h). Primary cultures of VECs and VSMCs were obtained from the SMAs by an explant technique as reported previously. 10 The VECs and VSMCs of third-to-fifth passages of identical quantities were mixed and co-cultured for 24 h. For hypoxia treatment, co-cultured cells were exchanged with serum-free media, added with reagents (e.g. exogenous Ang-1 and Ang-2) according to the treatments in different groups, and then hypoxiatreated as hypoxic SMAs.
2.4 Study design and experimental protocol 2.4.1 Role of Ang-1 and Ang-2 in the biphasic change of vascular reactivity after haemorrhagic shock
The protein expression of Ang-1 and that of Ang-2 in SMAs after haemorrhagic shock and hypoxia were measured via western blotting (n ¼ 4). The vascular reactivity of SMAs to endothelium-dependent acetylcholine (ACh) and endothelium-independent sodium nitroprusside (SNP) after haemorrhagic shock, the vascular reactivity of SMAs to norepinepherine (NE) after haemorrhagic shock and hypoxia, and the effects of exogenous Ang-1 and Ang-2 on the vascular reactivity of SMAs to NE after early and late hypoxia were observed via an isolated organ-perfusion system (DMT 610M, AD Instruments, Marietta, GA, USA) (n ¼ 8). 11 The effects of Ang-1 and Ang-2 siRNA on the vascular reactivity of VSMCs to NE after early and late hypoxia were observed via the leakage of fluorescein isothiocyanate (FITC)-labelled bovine serum albumin (BSA) (n ¼ 4). 12 The aim of this part of the experiment was to identify whether Ang-1 and Ang-2 were responsible for the biphasic change in vascular reactivity after haemorrhagic shock.
Relationship of Ang-1-and Ang-2-mediated regulation of vascular reactivity with Tie2 and NO after haemorrhagic shock
The protein expression of the Tie2 and alpha 1 adrenergic receptors in SMAs after haemorrhagic shock and the tyrosine phosphorylation of Tie2 and the effects of exogenous Ang-1 and Ang-2 as well as Ang-1 and Ang-2 siRNA on the protein expression and tyrosine phosphorylation of Tie2 in co-cultured VECs and VSMCs after early and late hypoxia were observed via western blotting and immunoprecipitation (n ¼ 4). 13 The NO concentration in blood plasma after haemorrhagic shock and the effects of exogenous Ang-1 and Ang-2 as well as Tie2 function-blocking antibody on the NO concentration in the medium of co-cultured VECs and VSMCs after early and late hypoxia were determined using a Nitric Oxide Assay Kit (n ¼ 8). The effect of Tie2 function-blocking antibody on the regulatory effects of exogenous Ang-1 and Ang-2 on the vascular reactivity of SMAs to NE after early and late hypoxia were observed via an isolated organ-perfusion system (n ¼ 8). The effect of Tie2 siRNA on the regulation of exogenous Ang-1 and Ang-2 on the vascular reactivity of VSMCs to NE after early and late hypoxia were observed via leakage of FITC-labelled BSA (n ¼ 4). This part of the experiment was undertaken to ascertain whether Ang-1 and Ang-2 regulate vascular reactivity after haemorrhagic shock through the Tie2-NO pathway.
2.4.3
Role of the Tie2-Akt-eNOS and Tie2-Erk-iNOS pathways on the different effects of Ang-1 and Ang-2 on vascular reactivity after haemorrhagic shock
The protein expression and phosphorylation of Akt, Erk, eNOS, and iNOS in SMAs after haemorrhagic shock were measured by western blotting (n ¼ 4). The effects of selective antagonists of Akt, Erk, eNOS, and iNOS on the regulatory effects of exogenous Ang-1 and Ang-2 on vascular reactivity in SMAs to NE after early and late hypoxia were observed via an isolated organ-perfusion system (n ¼ 8). The effects of exogenous Ang-1 and Ang-2, Tie2 function-blocking antibody, and Tie2 siRNA on the phosphorylation of Akt and Erk, as well as the effects of exogenous Ang-1 and Ang-2, Tie2 function-blocking antibody, and antagonists of Akt and Erk on the protein expression of eNOS and iNOS in co-cultured VECs and VSMCs after early and late hypoxia were observed by western blotting (n ¼ 4). The effects of selective antagonists of Akt, Erk, eNOS, and iNOS on the NO concentration in the medium of co-cultured VECs and VSMCs after early and late hypoxia was determined using a Nitric Oxide Assay Kit (n ¼ 8). This part of the experiment was done to observe whether Ang-1 and Ang-2 regulate vascular reactivity after haemorrhagic shock via different signal pathways: Tie2-Akt-eNOS or Tie2-Erk-iNOS.
Compounds and antibodies
Exogenous Ang-1 and Ang-2, the antibodies of eNOS and iNOS, the Akt inhibitor VIII trifluoroacetate salt hydrate, and PD98059 were purchased from Sigma -Aldrich (Saint Louis, MO, USA). The antibodies of Ang-1 and Ang-2 and the blocking antibody of Tie2 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The antibodies of Akt, phosphor-Akt (Ser473), Erk, and phosphor-Erk (Thr202/Tyr204) were purchased from Cell Signaling Technology (Danvers, MA, USA). L-NIO dihydrochloride and L-NIL hydrochloride were purchased from Tocris (Bristol, UK). The NO Assay kit was purchased from Merck KGaA (Darmstadt, Germany). The siRNAs of Ang-1, Ang-2, and Tie2 were purchased from Thermo Fisher Scientific, Inc. (Rockford, IL, USA).
The rabbit polyclonal antibody of the alpha 1 adrenergic receptor was purchased from Abcam, Inc. (Cambridge, UK).
Statistical analyses
Data are the mean + standard deviation of n observations. The difference between experimental groups was analysed by one-way or two-way analysis of variance, followed by a post hoc Tukey test. P , 0.05 was considered significant.
Results
3.1 Role of Ang-1 and Ang-2 in the biphasic change of vascular reactivity after haemorrhagic shock
Vascular reactivity of SMAs after haemorrhagic shock and hypoxia
The vascular reactivity of SMAs to NE after haemorrhagic shock showed a biphasic change. The maximal contraction (Emax) of NE at early shock (10 min) was increased by 29.3% compared with the normal control and gradually decreased at the prolonged stage (30 min, 1, 2, and 4 h) (P , 0.01, Figure 1A ). Hypoxia-treated SMAs also showed a biphasic change in vascular reactivity. The Emax of NE was increased after transient hypoxia (10 min and 1 h) and decreased after prolonged hypoxia (3, 4, and 5 h) (P , 0.01, Figure 1B ), whereas the pD2 ( -log[EC50]) of NE did not show a significant change (data not shown).
The values of the vascular reactivity of SMAs to endotheliumdependent ACh and to endothelium-independent SNP were both increased at early shock, and both decreased at late shock, which showed a tendency similar to that seen with the vascular contractile response to NE (Supplementary material online, Figure S1 ).
Protein expression of Ang-1 and Ang-2 in SMAs after haemorrhagic shock and hypoxia
The changes in Ang-1 and Ang-2 protein expression in SMAs after haemorrhagic shock and hypoxia were similar. The protein expression of Ang-1 was increased at the early stage of shock and hypoxia, peaked at 10 min, and decreased at the prolonged stage of shock and hypoxia (P , 0.01). The protein expression of Ang-2 did not change obviously at the early stage of shock and hypoxia, but increased significantly at the prolonged stage of shock and hypoxia (P , 0.01, Figure 1C and D).
Effects of exogenous
Ang-1 and Ang-2 as well as Ang-1 and Ang-2 siRNA on vascular reactivity after early and late hypoxia The decreased vascular contractile response and the consequent hypotension after severe shock was the focus of this study. Hence, the regulatory effect of the Ang-1,2/Tie2 system on vascular reactivity to NE after haemorrhagic shock was observed. In the vascular hyperreactivity stage of early hypoxia (10 min), exogenous administration of Ang-1 (200 ng/mL) maintained the increased vascular reactivity, whereas exogenous Ang-2 (200 ng/mL) weakened the increased vascular reactivity. In the vascular hyporeactivity stage of late hypoxia (4 h), exogenous Ang-1 improved the decreased vascular reactivity, whereas exogenous Ang-2 aggravated vascular hyporeactivity. These effects were reflected by the Emax of NE in SMAs (P , 0.01, Figure 1E ), and the pD2 of NE did not show a significant change. Ang-1 RNAi could antagonize the hyperreactivity of VSMCs after 10 min of hypoxia, and Ang-2 RNAi could antagonize the hyporeactivity of VSMCs after4 h of hypoxia (P , 0.01, Figure 1F ).
Role of Tie2 and NO in the regulation
of Ang-1 and Ang-2 on vascular reactivity after haemorrhagic shock 3.2.1 Protein expression and tyrosine phosphorylation of Tie2 and the concentration of NO after haemorrhagic shock The protein expression and tyrosine phosphorylation of Tie2 in SMAs were low in the normal control group and gradually increased after shock (P , 0.01, Figure 2A ). The NO concentration in blood plasma was also low in the normal control group, increased slightly after 10 min of shock, and gradually increased to a high level after 4 h of shock (P , 0.01, Figure 2D ).
The protein expression of the total alpha 1 adrenergic receptor did not change significantly at early shock (10 min) and only lightly increased at the late period of haemorrhagic shock (since 30 min), it did not change in a trend similar to that seen for NE-induced vascular contractile response (Supplementary material online, Figure S2 ).
Effect of Tie2 function-blocking antibody and Tie2
siRNA on the regulatory effects of exogenous Ang-1 and Ang-2 on vascular reactivity after early and late hypoxia The function-blocking antibody of Tie2 (1:100 dilution) could decrease vascular hyperreactivity and antagonize the maintenance effect of Ang-1 on vascular hyperreactivity after 10 min of hypoxia. It could also improve vascular hyporeactivity and antagonize the aggravating effects of Ang-2 on vascular hyporeactivity after 4 h of hypoxia. This was reflected by the Emax of NE in SMAs (P , 0.05 or P , 0.01, Figure 2E and F ), whereas the pD2 of NE changed very slightly. Tie2 RNAi could decrease the hyper-contraction of VSMCs under the stimulation of Ang-1 after 10 min of hypoxia and could improve the hypo-contraction of VSMCs under the stimulation of Ang-2 after 4 h of hypoxia (P , 0.01, Figure 2G ). 
Effects of exogenous
Ang-1 and Ang-2 on the protein expression and tyrosine phosphorylation of Tie2, and the concentration of NO, as well as the effects of Ang-1 and Ang-2 siRNA on the phosphorylation of Tie2 in cell mixtures after early and late hypoxia Exogenous Ang-2 (200 ng/mL) inhibited the slightly increased tyrosine phosphorylation of Tie2 and concentration of NO in a cell mixture of VECs and VSMCs after 10 min of hypoxia. Exogenous Ang-1 (200 ng/ mL) inhibited the appreciably increased protein expression and tyrosine phosphorylation of Tie2 and the concentration of NO in the cell mixture after 4 h of hypoxia (P , 0.01, Figure 2B and H ). The function-blocking antibody of Tie2 (1:100 dilution) could antagonize the change in NO concentration after 10 min and 4 h of hypoxia (P , 0.01, Figure 2H ). Ang-1 RNAi could decrease the phosphorylation of Tie2 after 10 min of hypoxia, and Ang-2 RNAi could decrease the phosphorylation of Tie2 after 4 h of hypoxia (P , 0.01, Figure 2C ).
Role of Tie2-Akt-eNOS and
Tie2-Erk-iNOS in the regulatory effects of Ang-1 and Ang-2 on vascular reactivity after haemorrhagic shock 3.3.1 Protein expression and phosphorylation of Akt, Erk, eNOS, and iNOS after haemorrhagic shock The phosphorylation of Akt and Erk and the protein expression of eNOS and iNOS in SMAs were increased obviously after haemorrhagic shock (P , 0.01, Figure 3A and B). The phosphorylation of Akt and the protein expression of eNOS were increased from early shock (10 min), whereas Erk phosphorylation and iNOS expression were increased at late shock (after 30 min). inhibited the increased vascular reactivity of SMAs and antagonized the maintenance effect of Ang-1 on vascular reactivity after 10 min of hypoxia (P , 0.01, Figure 4A and B). Antagonists of Erk (PD98059, 1 × 10 -5 mol/L) and iNOS (L-NIL hydrochloride, 1 × 10 -4 mol/L) improved the decreased vascular reactivity and inhibited the downregulatory effect of Ang-2 on vascular reactivity after 4 h of hypoxia (P , 0.01, Figure 4C and D). These effects were reflected by the Emax of NE, but not by the pD2 of NE. eNOS expression, and slight NO release after 10 min of hypoxia (P , 0.01, Figure 5A , B and E). Exogenous Ang-1 (200 ng/mL) and the function-blocking antibody of Tie2 (1:100 dilution) could inhibit the increased Erk phosphorylation, iNOS expression, and appreciable NO release after 4 h of hypoxia (P , 0.01, Figure 5A , C and F ). The antagonist of Akt could antagonize the change in eNOS and NO after 10 min of hypoxia. The antagonist of Erk could antagonize the change in iNOS and NO after 4 h of hypoxia. The antagonists of eNOS and iNOS could antagonize the change in NO after 10 min and 4 h of hypoxia, respectively (P , 0.01, Figure 5B-F) . Tie2 siRNA could decrease the phosphorylation of Akt under the stimulation of Ang-1 after 10 min of hypoxia and the phosphorylation of Erk under the stimulation of Ang-2 after 4 h of hypoxia (P , 0.01, Figure 5D ).
Effects of the selective antagonists of
Effects of exogenous
Discussion
Our previous study revealed that vascular reactivity shows a biphasic change (increased at early shock and decreased at the advanced stage) after severe trauma or shock and that its mechanism is incompletely Angiopoietins regulate vascular reactivity after shock understood. Ang-1 and Ang-2 (which competitively bind to the Tie2 receptor and regulate NO production) have critical roles in the remodelling, maturation, and stabilization of the vasculature. 7 Whether Ang-1 and Ang-2 participate in the regulation of biphasicchanged vascular reactivity after shock has not been determined.
The study discussed here revealed that the vascular contraction to NE and relaxation to ACh and SNP showed a similar biphasic change after haemorrhagic shock. The decreased vascular contractile response and the related mechanism after severe shock/trauma were the main objectives of this study, so we observed the role of the Ang-1,2/Tie2 system on the biphasic-changed vascular reactivity to NE after haemorrhagic shock. We found that the vascular reactivity after haemorrhagic shock was positively correlated with the protein expression of Ang-1, whereas it was negatively correlated with the protein expression of Ang-2. Exogenous Ang-1 maintained vascular hyperreactivity at early shock and improved hyporeactivity at late shock, whereas exogenous Ang-2 inhibited vascular hyperreactivity at early shock and aggravated hyporeactivity at late shock. Ang-1 siRNA could decrease hyperreactivity at early shock, and Ang-2 siRNA could improve hyporeactivity at late shock. This finding suggested that Ang-1 and Ang-2 participated in the regulation of biphasicchanged vascular reactivity after haemorrhagic shock. It also suggested that Ang-1 was responsible for the hyperreactivity at early shock and Ang-2 was responsible for the hyporeactivity at late shock.
Further studies revealed that the expression of Tie2 and NO release were slightly increased at early shock and greatly increased at late shock. Tie2-blocking antibody and Tie2 siRNA antagonized the maintenance effect of Ang-1 on vascular reactivity at early shock and the downregulatory effect of Ang-2 at late shock. The phosphorylation of Akt and Erk and the protein expression of eNOS and iNOS were also increased after shock. Antagonists of Akt and eNOS could antagonize Ang-1-induced maintenance of vascular reactivity and the slight release of NO at early shock. Antagonists of Erk and iNOS could antagonize the Ang-2-induced decrease in vascular reactivity and considerable release of NO at late shock. These results suggested that Ang-1 led to vascular hyperreactivity at early shock mainly through the Tie2-Akt-eNOS pathway and an appropriate amount of NO release and that Ang-2 led to vascular hyporeactivity at late shock mainly through the Tie2-Erk-iNOS pathway and the release of a large amount of NO.
Nicholas et al. 7 reported that Ang-1 and Ang-2 had competitive regulatory effects on Tie2: Ang-1 could phosphorylate and activate Tie2, but Ang-2 could not. The present study revealed that Ang-2 may also act as an agonist of Tie2 and that increased Ang-2 could lead to significant tyrosine phosphorylation of Tie2 at late shock. This phenomenon has also been observed in other cells and conditions. For example, Harfouche and Hussain 14 reported that 100 ng/mL of Ang-2 could inhibit Ang-1-induced Tie2 phosphorylation, whereas 300-800 ng/mL of Ang-2 could elicit high-level activation of Tie2 in human umbilical vein endothelial cells. Teichert-Kuliszewska et al. 15 reported that 24-h pretreatment with Ang-2 followed by brief re-exposure could activate Tie2 phosphorylation in VECs. Ang-1 routinely activates Tie2, but the present study revealed that exogenous Ang-1 inhibited the appreciably increased protein expression and phosphorylation of Tie2 at late shock, which suggested that Ang-1 was involved in a feedback system to prevent the over-activation of Tie2. The feedback effect of Ang-1 to Tie2 has been reported in several studies, 16, 17 but its detailed mechanism is not clear. Studies have revealed that the transcription factor NERF2 could bind to the promoter region of Tie2 and transactivate Tie2 expression in response to hypoxia and was regulated by Ang-1 in human umbilical vein endothelial cells. 18 In VECs, Ang-1 could activate the PI3-K/Akt pathway, provide negative feedback on the transcription of Ang-2, and reduce Ang-2 release. 19 This suggested that the feedback effect of Ang-1 had important roles in the regulation of Ang-2 and Tie2. Another interesting issue shown in the present study was that Ang-1-and Ang-2-regulated vascular reactivity through the Tie2 receptor and then via different signal pathways in different period: Akt-eNOS at early shock and Erk-iNOS at late shock. However, further investigation is necessary to obtain insights into the detailed mechanism. A study by Fukuhara et al. provided a possible interpretation-the location of Tie2. Tie2 could locate at cell -cell contacts and cell -extracellular matrix (ECM) contacts in VECs, and the two types of Tie2 location may have different effects: Tie2 at cellcell contacts may preferentially activate Akt, and Tie2 at cell -ECM contacts may preferentially activate Erk. Formation of the ECM-anchored Tie2 complex is dependent upon the presence or absence of cell-cell adhesion; and Tie2 is recruited to cell-ECM contacts in the absence of cell -cell contacts. 20 Hence, the injured (or even lost) cell -cell contacts after shock or hypoxia 21 may cause Tie2 to activate Akt at early shock and activate Erk at late shock. Even in this case, further investigation is necessary to obtain insights into the detailed mechanism. The present study revealed that different amounts of NO had different roles in the regulation of vascular reactivity after haemorrhagic shock. This supported the notion that NO is a 'double-edged sword' and that the effect is decided mainly by its amount: the appropriate amount of NO induced by eNOS is protective, and over-production of NO induced by iNOS is harmful. 22, 23 As a generally accepted view, NO is a vasodilator and not a constrictor, and it seems absurd that an appropriate amount of NO generated from early shock is responsible for increased vascular contractility. In fact, the vascular hyperreactivity at early shock does not benefit from the decrease in vasodilator factors but from the functional protection of certain substances. According to the present study, the appropriate amount of NO offered protection at early shock. A similar protective function of an appropriate amount of NO has been observed in several reports. For example, an appropriate amount of NO induced by eNOS showed protective effects on intestinal injury after shock due to occlusion of the splanchnic artery, and an eNOS-derived appropriate amount of NO showed neurovascular protective effects against aneurysmal subarachnoid haemorrhageinduced delayed cerebral ischaemia. 22, 25 Our results showed that the protein expression of Ang-1 was increased at 10 min of shock, but how it could increase at such a high speed is not known. Through immunoelectron microscopy, some studies found that Ang-2 (another member of the Ang family) was in Weibel-Palade bodies in the cytoplasm of endothelial cells and that this localization of protein in a subcellular organ could facilitate the rapid release of Ang-2 upon stimulation. 26, 27 Ang-1 and Ang-2 share a 60% amino acid identity, so the storage and release of Ang-1 may have the same mechanism as that seen with Ang-2 and the rapid increase in Ang-1 may also be because of its rapid release. Figure 6 Signal cascade for the regulation of Ang-1 and Ang-2 on vascular reactivity after haemorrhagic shock (schematic).
In the present study, NE was chosen as the tool to observe vascular reactivity after haemorrhagic shock. The alpha 1 adrenergic receptor is the main receptor for NE, so maybe the change in vascular reactivity after haemorrhagic shock was induced by changes in the alpha 1 adrenergic receptor. We observed changes in the alpha 1 adrenergic receptor after haemorrhagic shock. The protein expression of the alpha-1 adrenergic receptor did not change significantly at early shock and only slightly increased in the late period of haemorrhagic shock. However, vascular reactivity after haemorrhagic shock was increased at early shock and decreased at late shock, which could not be explained by changes in the alpha 1 adrenergic receptor. This result suggested that the changes in vascular reactivity after shock did not arise from changes in the alpha 1 adrenergic receptor, but was a comprehensive effect arising from changes in vascular function.
To exclude certain complicated interference factors in vivo and to better elucidate the role of Ang-1 and Ang-2 and their related mechanisms, hypoxia treatment in vitro was used to mimic haemorrhagic shock in vivo on the basis of previous research because hypoxia and ischaemia are the major factors contributing to the pathogenesis of haemorrhagic shock. 11 The present study demonstrated that the contractile response of SMAs under hypoxia treatment in vitro showed a biphasic change similar to that observed after haemorrhagic shock in vivo. This finding suggested that hypoxia-treated SMAs in vitro could model the hypoxic-ischaemic condition of shock. This model of hypoxia can only partially mimic the shocked state, and a more complete model is needed to mimic the conditions of shock. The present study elucidated the regulatory effects of Ang-1 and Ang-2 on vascular reactivity after shock and their possible mechanisms. Nevertheless, several issues must be answered in future studies. First, the present study was limited to rodents, the regulatory effects of Ang-1 and Ang-2 need to be identified in large animals. Secondly, a more complete model needs to be created to mimic the shocked state. Thirdly, further investigation is needed to obtain insights into the detailed mechanism whereby Ang-1 and Ang-2 regulate the Tie2-Akt-eNOS and Tie-Erk iNOS pathways.
Conclusion
The present study suggested that Ang-1 and Ang-2 participated in the regulation of the biphasic change of vascular reactivity after haemorrhagic shock. Ang-1 was mainly responsible for hyperreactivity at early shock through the Tie2-Akt-eNOS pathway and the release of an appropriate amount of NO. Ang-2 was mainly responsible for hyporeactivity at late shock through the Tie2-Erk-iNOS pathway and the release of a large amount of NO ( Figure 6 ).
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